| Primary |
| Cheilitis |
18.8% |
| Stomatitis |
18.8% |
| Premedication |
15.6% |
| Cervix Carcinoma Recurrent |
12.5% |
| Vaginal Discharge |
12.5% |
| Haemoglobin |
6.3% |
| Nausea |
6.3% |
| Anaemia |
3.1% |
| Prophylaxis |
3.1% |
| Pyrexia |
3.1% |
|
| Extrapyramidal Disorder |
66.7% |
| Congestive Cardiomyopathy |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
40.2% |
| Drug Use For Unknown Indication |
13.4% |
| Nausea |
5.7% |
| Drug Exposure During Pregnancy |
5.4% |
| Prophylaxis |
5.4% |
| Pain |
4.2% |
| Premedication |
3.2% |
| Vomiting |
2.9% |
| Non-hodgkin's Lymphoma |
2.5% |
| Acute Myeloid Leukaemia |
2.3% |
| Diarrhoea |
2.2% |
| Non-hodgkin's Lymphoma Unspecified Histology Aggressive Refractory |
2.0% |
| Pneumonia Aspiration |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.6% |
| Chemotherapy |
1.3% |
| Epilepsy |
1.3% |
| Gastrointestinal Motility Disorder |
1.3% |
| Lung Infection |
1.2% |
| Anxiety |
1.0% |
| Depression |
1.0% |
|
| Hypertriglyceridaemia |
8.6% |
| Hyponatraemia |
7.5% |
| Thrombocytopenia |
7.5% |
| Vomiting |
7.5% |
| Premature Baby |
6.5% |
| Toxic Skin Eruption |
6.5% |
| Monocytopenia |
5.4% |
| Visual Impairment |
5.4% |
| Interstitial Lung Disease |
4.3% |
| Pulmonary Alveolar Haemorrhage |
4.3% |
| Right Ventricular Failure |
4.3% |
| Sinus Bradycardia |
4.3% |
| Transaminases Increased |
4.3% |
| Weight Increased |
4.3% |
| Abnormal Behaviour |
3.2% |
| Hepatocellular Injury |
3.2% |
| Hypokalaemia |
3.2% |
| Liver Disorder |
3.2% |
| Sepsis |
3.2% |
| Staphylococcal Infection |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.2% |
| Drug Use For Unknown Indication |
15.0% |
| Prophylaxis |
13.0% |
| Nausea |
7.1% |
| Chronic Hepatitis C |
6.6% |
| Pain |
5.3% |
| Hypertension |
5.2% |
| Constipation |
4.0% |
| Premedication |
2.6% |
| Insomnia |
2.3% |
| Vomiting |
2.3% |
| Diarrhoea |
2.0% |
| Cancer Pain |
2.0% |
| Hepatitis C |
2.0% |
| Prophylaxis Of Nausea And Vomiting |
2.0% |
| Colon Cancer |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Infection Prophylaxis |
1.7% |
| Gastritis |
1.6% |
| Stem Cell Transplant |
1.4% |
|
| White Blood Cell Count Decreased |
15.5% |
| Vomiting |
13.6% |
| Pyrexia |
8.3% |
| Thrombocytopenia |
6.9% |
| Weight Decreased |
6.5% |
| Stomatitis |
5.4% |
| Nausea |
5.2% |
| Sepsis |
3.6% |
| Neutrophil Count Decreased |
3.5% |
| Renal Failure Acute |
3.5% |
| Platelet Count Decreased |
3.3% |
| Tubulointerstitial Nephritis |
3.3% |
| Pulmonary Embolism |
3.1% |
| Death |
2.7% |
| Interstitial Lung Disease |
2.7% |
| Neutropenia |
2.7% |
| Rash |
2.7% |
| Renal Impairment |
2.7% |
| Toxic Epidermal Necrolysis |
2.7% |
| Malaise |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
38.1% |
| Hypertension |
9.5% |
| Acid Base Balance |
4.8% |
| Acid Base Balance Abnormal |
4.8% |
| Antiallergic Therapy |
4.8% |
| Cerebral Haemorrhage |
4.8% |
| Dizziness |
4.8% |
| Epilepsy |
4.8% |
| Gastrointestinal Disorder |
4.8% |
| Haemostasis |
4.8% |
| Migraine |
4.8% |
| Procoagulant Therapy |
4.8% |
| Smoking Cessation Therapy |
4.8% |
|
| Shock |
40.0% |
| Drug Interaction |
20.0% |
| Dysphagia |
20.0% |
| White Blood Cell Count Decreased |
20.0% |
|
